NeoStem completes direct public offering

NeoStem Inc. (NYSE-A:NBS), New York, N.Y. Business: Gene/Cell therapy, Supply/Service Date completed: 6/25/10 Type: Direct public offering Raised: $5 million Units: 2.3 million Price: $2.15 (unit) Sha...